{
  "ptid_time": "037_S_0552_2006-05-24",
  "img_path": "/data/qiuhui/data/adni/images/037_S_0552/2006-05-24/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 54,639 mm³, 144.6% above the reference mean. With a Z-score of 3.62 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 5,527 mm³, 28.1% below the reference mean. With a Z-score of -3.15 (0.1th percentile), this represents profound atrophy; whole brain volume measures 877,467 mm³, 14.7% below the reference mean. With a Z-score of -1.83 (3.3th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,430 mm³, 11.9% below the reference mean. With a Z-score of -0.92 (17.8th percentile), this represents normal volume ; fusiform gyrus volume measures 15,365 mm³, 15.6% below the reference mean. With a Z-score of -1.76 (3.9th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 16,865 mm³, 17.8% below the reference mean. With a Z-score of -1.58 (5.7th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 60.1 years. Gender is Female. Education: 19 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Major Surgical Procedures. MMSE: 27.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 648.40 pg/mL (normal ); Total tau: 384.10 pg/mL (moderate elevated); Phosphorylated tau: 39.15 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound hippocampal atrophy and moderate atrophy in whole brain, fusiform gyrus, and middle temporal gyrus, alongside significant ventricular enlargement. Elevated P-tau and T-tau with normal Aβ suggest Alzheimer’s pathology (likely tauopathy). Despite a near-normal MMSE (27), the structural and biomarker changes indicate neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s disease, non-amyloid subtype or primary age-related tauopathy).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but MCI diagnosis is provisional without detailed cognitive testing beyond MMSE).  \n\n*Note:* The MMSE is relatively preserved, but the structural/biomarker severity suggests early dementia cannot be ruled out. Follow-up with neuropsychological testing (e.g., episodic memory scores) would refine staging.",
  "timestamp": "2025-07-26T06:32:07.413013"
}